92470-31-0

Basic information

• Product Name: Amrubicinhydrochloride
• Synonyms: Amrubicin HCL;(7S-cis)-9-Acetyl-9-amino-7-[(2-deoxy-alpha-D-erythro-pentopyranosyl)oxy]-7,8,9,10-tetrahydro-6,11-dihydroxy-5,12-naphthacenedione hydrochloride
• CAS NO: 92470-31-0
• Molecular Formula: C25H25NO9.HCl
• Molecular Weight: 519.94027
• Mol File: 92470-31-0.mol
• Article Data: 0

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Amrubicinhydrochloride(CAS DataBase Reference)
• NIST Chemistry Reference: Amrubicinhydrochloride(92470-31-0)
• EPA Substance Registry System: Amrubicinhydrochloride(92470-31-0)

Safety Data

• Hazardous Substances Data: 92470-31-0(Hazardous Substances Data)

Usage

General Description

Amrubicin hydrochloride is a synthetic anthracycline anticancer drug that is used in the treatment of various types of cancer, including small cell lung cancer and ovarian cancer. It works by inhibiting the growth of cancer cells and inducing apoptosis. Amrubicin hydrochloride is administered via intravenous infusion and is often used as a second or third line treatment when other chemotherapy regimens have failed. Side effects may include bone marrow suppression, nausea, vomiting, and hair loss. It is important to closely monitor patients receiving amrubicin hydrochloride for any signs of adverse reactions and to adjust the dosage as necessary to ensure effective treatment while minimizing side effects.